Argenx Se Share Price: ARGX (Argenx Se) Stock Price Today & Updates | INDmoney

Question 1

What is Argenx Se share price today?

Accepted Answer

Argenx Se (ARGX) share price today is {{live_price}}.

Question 2

Can Indians buy Argenx Se shares?

Accepted Answer

Yes, Indians can invest in the Argenx Se (ARGX) from India.

With INDmoney, you can buy Argenx Se at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Argenx Se at zero transaction cost.

Question 3

How can I buy Argenx Se shares from India?

Accepted Answer

It is very easy to buy Argenx Se from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Argenx Se be purchased?

Accepted Answer

Yes, you can buy fractional shares of Argenx Se with INDmoney app.

Question 5

What are the documents required to start investing in Argenx Se stocks?

Accepted Answer

To start investing in Argenx Se, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Argenx Se

Accepted Answer

Today’s highest price of Argenx Se (ARGX) is {{1_rba_end}}.

Today’s lowest price of Argenx Se (ARGX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Argenx Se

Accepted Answer

Today's market capitalisation of Argenx Se ARGX is 32.8B

Question 8

What is the 52 Week High and Low Range of Argenx Se

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Argenx Se is down from its 52 Week High?

Accepted Answer

Argenx Se (ARGX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Argenx Se is up from its 52 Week low?

Accepted Answer

Argenx Se (ARGX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Argenx Se?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Argenx Se

Accepted Answer

Mr. Timothy  Van Hauwermeiren EMBA, M.Sc. is the current Chief Executive Officer (CEO) of Argenx Se.

Period	Argenx Se	Sector (Health Care)	Index (Russel 2000)
3 Months	22.56%	3.6%	0.0%
6 Months	53.22%	10.2%	0.0%
1 Year	18.86%	19.6%	0.0%
3 Years	92.07%	16.8%	-23.0%

Market Capitalization	32.8B
Book Value	$71.28
Earnings Per Share (EPS)	-3.51
PEG Ratio	0.0
Wall Street Target Price	551.45

Profit Margin	-12.31%
Operating Margin TTM	-8.98%

Return On Assets TTM	-5.51%
Return On Equity TTM	-5.74%

Revenue TTM	1.7B
Revenue Per Share TTM	1.12
Quarterly Revenue Growth YOY	74.2%
Gross Profit TTM	-251.8M
EBITDA	-242.5M
Diluted Eps TTM	-3.51
Quarterly Earnings Growth YOY	0.0

Argenx Se (ARGX)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Vs ALNY

Institutional Holdings

Corporate Announcements

Argenx Se Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.4
EPS Estimate Next Year	6.61
EPS Estimate Current Quarter	-0.98
EPS Estimate Next Quarter	-0.61

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Argenx Se	6.91%	53.22%	18.86%	92.07%	391.9%
Regeneron Pharmaceuticals, Inc.	-9.28%	10.06%	24.53%	74.0%	232.45%
Novo Nordisk A/s	-4.54%	-5.72%	21.59%	126.2%	349.01%
Alnylam Pharmaceuticals, Inc.	8.87%	102.98%	82.67%	44.83%	241.09%
Vertex Pharmaceuticals Incorporated	5.0%	20.77%	31.37%	158.16%	163.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Argenx Se	NA	NA	0.0	-0.4	-0.06	-0.06	NA	71.28
Regeneron Pharmaceuticals, Inc.	26.41	26.41	1.37	44.9	0.17	0.08	NA	261.41
Novo Nordisk A/s	40.21	40.21	1.81	3.36	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.42	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.59	0.18	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Argenx Se	Buy	$32.8B	391.9%	NA	-12.31%
Regeneron Pharmaceuticals, Inc.	Buy	$110.0B	232.45%	26.41	32.04%
Novo Nordisk A/s	Buy	$529.8B	349.01%	40.21	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$38.1B	241.09%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$128.7B	163.17%	32.84	-4.74%

Organization	Argenx Se
Employees	1148
CEO	Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Industry	Health Technology